Últimas noticias sobre Northann (AMEX:NCL) Bolsa

Northann

Northann Corp specialized in 3D-printed flooring solutions under its flagship brand, "Benchwick." The company's operations span the full spectrum of additive manufacturing, from sourcing recycled ocean plastics to the final production of intricate flooring designs. Northann offers an extensive range of proprietary solutions, including Infinite Glass, DSE, TruBevel, and MattMaster, primarily through its sales network in North America and Europe.

Northann Corp

Norwegian Cruise Line Holdings Ltd. Ordinary Shares

Norwegian Cruise Line Holdings Ltd

Netcall PLC

NITORI HOLDINGS CO LTD by Nitori Holdings Co., Ltd.

Nitori Holdings Co Ltd

NITORI HOLDINGS CO U/ADR by Nitori Holdings Co., Ltd.

<p>Enhancing Productivity And Customer Satisfaction; New Platform Integrates Marketing, Sales, And Customer Service Solutions Across Multiple Channels, Including WhatsApp, Email, SMS, And Apps</p>


News

ZENV

Zenvia Launches AI-Powered Customer Cloud To Revolutionize Brand-Customer Experiences

Macro Economic Events

Market Summary

Economics

General

$BTC

NVDA

Benzinga Market Summary: Morgan Stanley And US Bank Shares Rise On Strong Earnings, Bitcoin Rises Above $67K, NVIDIA Recovers After Tuesday's Selloff

<p>The cryptocurrency industry emerged as a major player in the <a href="https://www.benzinga.com/general/politics/24/10/41347642/harris-vs-trump-vice-president-holds-lead-in-2024-election-poll-but-former-president-is-closing-">2024 U.S. election cycle</a>. </p>
<p><strong>What Happened</strong>: According to recent reports from CNBC and Politico, crypto-linked political action committees (PACs) and donors have contributed significant sums to both Republican and Democratic candidates, with a particular focus on key congressional races.</p>
<p>A pro-<strong>Donald Trump</strong> PAC, the Trump 47 Committee, raised approximately $7.5 million in cryptocurrency donations since early June, CNBC <a href="https://www.cnbc.com/2024/10/15/trump-pac-has-raised-about-7point5-million-in-crypto-donations.html">reported</a> on Wednesday.</p>
<p>These contributions include popular cryptocurrencies like <strong>Bitcoin</strong> (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>), <strong>Ethereum</strong> (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/eth/usd">ETH</a>), <strong>XRP</strong> (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/xrp/usd">XRP</a>) and stablecoins like <strong>USDC</strong> (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/">USDC</a>). The donations come from a diverse group of supporters across more than 15 states, including battleground regions.</p>
<p><strong>Also Read: <a href="https://www.benzinga.com/news/24/10/41348386/trump-falls-3-points-behind-harris-in-new-poll-economic-worries-dominate-voter-concerns-report">Trump Falls 3 Points Behind Harris In New Poll, Economic Worries Dominate Voter Concerns: Report</a></strong></p>
<p>Notable contributors include <strong>David Bailey</strong>, CEO of <strong>BTC Inc.</strong>, the parent company of Bitcoin Magazine. </p>
<p>Bailey, who donated over $498,000 in Bitcoin, is part of a group that helped shift Trump&#8217;s stance on cryptocurrency <a href="https://www.benzinga.com/markets/cryptocurrency/24/07/39801662/the-real-reason-why-donald-trump-has-pivoted-towards-crypto">from skepticism</a> to <a href="https://www.benzinga.com/markets/cryptocurrency/24/09/40743776/trump-reiterates-plans-to-make-us-world-capital-of-crypto-instead-of-attacking-industries-">enthusiasm</a>. </p>
<p>Other significant donors include <strong>Mike Belshe</strong>, CEO of BitGo, and <strong>Stuart Alderoty</strong>, Ripple&#8217;s legal chief, who contributed $300,000 in XRP.</p>
<p>On the Democratic side, Ripple co-founder <strong>Chris Larsen</strong> donated $1 million worth of XRP to Future Forward, a super PAC supporting Vice President <strong>Kamala Harris</strong>&#8216;s presidential bid. This highlights the non-partisan nature of crypto industry support, with donations flowing to candidates on both sides of the aisle.</p>
<p><figure class="wp-block-image size-full"><a href="https://www.benzinga.com/events/digital-assets/ "><img loading="lazy" decoding="async" width="300" height="250" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/03/29155259/905735A6-57D3-4874-9AA1-75D037842DB3-2.gif" alt="Benzinga Future of Digital Assets conference" class="wp-image-270548" /></a></figure></p>
<p><strong>Why It Matters:</strong> While the crypto industry is investing heavily in political campaigns, their messaging rarely mentions cryptocurrency directly. </p>
<p>Politico <a href="https://www.politico.com/news/2024/10/15/crypto-election-ads-fairshake-00183700">reported</a> on Monday that crypto-backed super PACs like Defend American Jobs, Protect Progress, and Fairshake have collectively spent $125 million on independent expenditures this cycle, accounting for 8% of all outside spending in congressional races. </p>
<p>However, their ads focus on general issues such as the economy, border security and candidates&#8217; biographies rather than crypto-specific topics.</p>
<p>The industry&#8217;s approach reflects a strategic decision to support candidates who are favorable to crypto interests without necessarily making cryptocurrency a central campaign issue. </p>
<p>Many of the backed candidates have supported key legislative priorities for the crypto industry, such as the bill to establish regulatory authority for different classes of digital assets.</p>
<p>The surge in crypto-related political spending comes as the industry seeks to influence future regulations and gain more mainstream acceptance. Senator&nbsp;<strong>Elizabeth Warren</strong>&nbsp;(D-Mass.) and her Republican challenger&nbsp;<strong>John Deaton</strong> sparred over crypto-related questions in their debate <a href="https://www.benzinga.com/markets/cryptocurrency/24/10/41350336/elizabeth-warren-says-rival-john-deaton-wants-to-go-to-washington-to-fight-for-his-crypto-">on Tuesday evening.</a></p>
<p><strong>Read Next:&nbsp;</strong></p>
<ul>
<li><strong><a href="https://www.benzinga.com/markets/cryptocurrency/24/10/41341588/donald-trumps-world-liberty-financial-token-sales-hit-220m-in-first-hour-website-faces-mul">Donald Trump&#8217;s World Liberty Financial Token Sales Hit $220M In First Hour, Website Faces Multiple Outages</a></strong></li>
</ul>
<p><em>Image via Unsplash</em></p>


Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$ETH

$USDC

$XRP

Crypto Lobbyists Are Quietly Influencing 2024 Election: This Is Their Playbook

<p>Goldman Sachs  analyst Alexander Blostein   maintains Charles Schwab (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SCHW#NYSE">SCHW</a>) with a Neutral and raises the price target from $67 to $74.</p>


Price Target

Analyst Ratings

SCHW

Goldman Sachs Maintains Neutral on Charles Schwab, Raises Price Target to $74

<p>Goldman Sachs  analyst Matthew Sykes   maintains CareDx (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CDNA#NASDAQ">CDNA</a>) with a Buy and raises the price target from $26 to $35.</p>


CDNA

Goldman Sachs Maintains Buy on CareDx, Raises Price Target to $35

ASML

ASML CEO Says That Without Demand For Artficial Intelligence, Chip Market Would Be "Sad"

WIIM

CGEM

Cullinan Therapeutics shares are trading higher after the FDA cleared the company's IND application for CLN-978.

Wave Life Sciences shares are trading higher following proof-of-mechanism data from its study of WVE-006 for alpha-1 antitrypsin deficiency.

Earnings

Abbott Executive Says Volume-Based Procurement In China Impacted Core Lab Business Sales; New OTC Glucose Monitor Lingo's 2-Sensor Pack Is Most Popular In U.S., With U.S. Reorder Rates Higher Than U.K.

<p>On Wednesday, smart platform technology company <strong>SKYX Platforms Corp</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SKYX#NASDAQ">SKYX</a>) (SKYX Technologies) announced a collaboration with home décor website <strong>Wayfair Inc</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/W#NYSE">W</a>)for its advanced and smart plug-and-play products.</p>
<p>SKYX will offer a wide variety of its advanced and smart plug-and-play products, including retrofit kits, plug-and-play smart light fixtures, ceiling fans, recessed lights, and ceiling outlet receptacles.</p>
<p>In the coming weeks, SKYX will likely offer its advanced and smart products on Wayfair&#8217;s website.</p>
<p>Steve Schmidt, President of SKYX, said, &#8220;I view this collaboration as a great growth opportunity for us and Wayfair, as our technology offers a variety of products for both retail and professional segments, that is a growing category for Wayfair.&#8221;</p>
<p>Rani Kohen, Founder and Executive Chairman of SKYX, said: &#8220;This is a significant opportunity to enhance our market penetration to both retail and professional channels, including architects, designers, and home decorators.&#8221;</p>
<p>SKYX has a series of advanced-safe-smart platform technologies, with over 97 U.S. and global patents and patent pending applications. Additionally, the company owns over 60 lighting and home decor websites for both retail and commercial segments. Our technologies place an emphasis on high quality and ease of use, while significantly enhancing both safety and lifestyle in homes and buildings.</p>
<p><strong>Price Action: </strong>SKYX stock is down 2.34% at $1.25 at the last check on Wednesday.</p>


Market-Moving Exclusives

Exclusives

SKYX

EXCLUSIVE: SKYX Platforms Partners with Wayfair to Launch Smart Plug-and-Play Home Products

AMZN

Amazon Launches New Kindle Lineup Featuring First-Ever Color Kindle, Reimagined Kindle Scribe With Enhanced Writing Capabilities, Fastest Kindle Paperwhite, And Compact Entry Kindle In Matcha Color

EXCLUSIVE: SKYX Tells Benzinga Co. Announces A Collaboration With Wayfair For Its Advanced And Smart Plug & Play Lighting For Retail And Professional Segments Including Designers And Architects

<p>Keefe, Bruyette &amp; Woods  analyst David Konrad   maintains PNC Finl Servs Gr (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PNC#NYSE">PNC</a>) with a Underperform and raises the price target from $180 to $182.</p>


Keefe, Bruyette & Woods Maintains Underperform on PNC Finl Servs Gr, Raises Price Target to $182

<p>Wedbush  analyst Seth Basham   reiterates CarMax (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KMX#NYSE">KMX</a>) with a Outperform and maintains $95 price target.</p>


Reiteration

Wedbush Reiterates Outperform on CarMax, Maintains $95 Price Target

<p>Keefe, Bruyette &amp; Woods  analyst David Konrad   maintains Goldman Sachs Gr (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GS#NYSE">GS</a>) with a Outperform and raises the price target from $555 to $570.</p>


Keefe, Bruyette & Woods Maintains Outperform on Goldman Sachs Gr, Raises Price Target to $570

Contracts

AIFF

DRUG

Firefly Neuroscience Collabs With Bright Minds Bioscience To Analyze Data From Phase 1 Study Using  AI, FDA-Cleared BNA Technology

<p>At the recent <strong><a href="https://www.benzinga.com/events/">Benzinga Cannabis Capital Conference</a></strong>, <strong>Tony Schor</strong>, CEO of <strong>Investor Awareness</strong>, offered a candid look into the challenges and opportunities facing cannabis companies, particularly in the realm of mergers and acquisitions (M&amp;A). Schor, a seasoned expert in the cannabis industry, discussed how companies are <a href="https://www.linkedin.com/posts/benzinga_yesterday-benzingas-abbey-higginbotham-activity-7249958067725856769-_mwn?utm_source=share&amp;utm_medium=member_desktop">navigating financial obstacles</a> while finding creative ways to secure capital and expand in a tightening market.</p>
<h4 class="wp-block-heading">M&amp;A Activity Picks Up in Cannabis</h4>
<p>Schor pointed to a renewed focus on companies with strong revenue streams as mergers and acquisitions gain traction. &#8220;People are looking for revenue-producing, not necessarily distressed, but revenue-generating cannabis companies,&#8221; he said, noting that investors are accumulating these assets for future sales opportunities.</p>
<p>Schor emphasized that the M&amp;A landscape is changing. &#8220;It's not necessarily the large MSOs doing the transactions, but new independents and cannabis operators who have left and now are coming back to the space,&#8221; he said.</p>
<h4 class="wp-block-heading">Capital Challenges Remain a Major Hurdle</h4>
<p>A recurring theme in Schor's discussion was companies&#8217; difficulty securing capital, regardless of their size or market position. &#8220;Cash capital is tough to find,&#8221; he stressed. Both public and private cannabis companies are feeling the squeeze, with public markets offering limited opportunities for growth and private companies struggling to access institutional money.</p>
<p>&#8220;Private companies are finding money, but their end game is to go public,&#8221; Schor added, highlighting the long-term goals many cannabis businesses have. However, the lack of access to federal banking presents a significant challenge, limiting growth potential. &#8220;Without federal banking reforms, institutional support remains out of reach,&#8221; Schor said.</p>
<h4 class="wp-block-heading">The Power of Partnerships</h4>
<p>Schor concluded with a call to action for cannabis businesses to embrace partnerships to overcome capital constraints and expand their operations. He stressed the importance of collaboration in the industry and offered practical advice for brands looking to enter new markets. &#8220;The only way this industry survives is if you talk to a new person and discuss potential collaborations and partnerships,&#8221; Schor said.</p>
<p>Partnerships can be a lifeline for companies looking to grow without heavy capital investment. &#8220;Perhaps you're a brand in Colorado and want to go to other markets, but you don't have the capital. Find another brand or a manufacturing partner in another market,&#8221; Schor said, highlighting how businesses can expand without taking on significant financial risk.</p>
<p> Schor's insights at the conference provided a roadmap for cannabis companies grappling with financial hurdles and seeking ways to grow. By focusing on revenue-producing acquisitions, navigating capital challenges, and leveraging partnerships, cannabis businesses can better position themselves for success in an increasingly competitive environment.</p>
<hr class="wp-block-separator has-alpha-channel-opacity" />
<p><em>Don&#8217;t miss your chance to be part of Cannabis Market Spotlight: California in Anaheim on Nov. 12. Whether you&#8217;re looking to connect with industry leaders, explore investment opportunities, or gain the latest insights into California&#8217;s cannabis market, this event has it all.&nbsp;<a href="https://cannabismarketspotlight.com/california/anaheim-november-12/" target="_blank" rel="noreferrer noopener">Secure your spot today!</a></em></p>
<p><em>Get Benzinga&#8217;s exclusive analysis and the top news about the cannabis industry and markets daily in your inbox for free. <a href="https://newsletteremail.benzinga.com/subscribe?_gl=1&#x2A;1ajl6va&#x2A;_gcl_au&#x2A;NjI5OTQ1MTM5LjE3Mjc5MzA5MjI.&#x2A;_ga&#x2A;MTAyOTE3MTY5OC4xNzI3OTMwOTIy&#x2A;_ga_V7ZK73W7N0&#x2A;MTcyODkxMjAzOS41LjEuMTcyODkxMjEyMC4wLjAuMA.." target="_blank" rel="noreferrer noopener">Subscribe</a> to our newsletter here. If you&#8217;re serious about the business, you can&#8217;t afford to miss out.</em></p>
<p><strong>Read Next:</strong></p>
<ul>
<li><a href="https://www.benzinga.com/markets/cannabis/24/10/41356399/thc-beverages-could-revive-struggling-alcohol-industry-expert-says-partying-stress-and-anxiety-h"><strong>THC Beverages Could Revive Struggling Alcohol Industry, Expert Says: &#8216;Partying, Stress And Anxiety Haven&#8217;t Diminished&#8217;</strong></a></li>
</ul>
<p><em>Photo: Courtesy of Sora Shimazaki by Pexels</em></p>


Cannabis

Events

Interview

How Cannabis Companies Can Thrive: 'Cash Capital Is Tough To Find,' But Partnerships Hold The Key

<p>Keefe, Bruyette &amp; Woods  analyst Catherine Mealor   maintains FB Financial (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FBK#NYSE">FBK</a>) with a Market Perform and raises the price target from $48 to $50.</p>


Keefe, Bruyette & Woods Maintains Market Perform on FB Financial, Raises Price Target to $50

<p>Continues As Proud Partner Of Youth Sports Day, Hosts Events With Coaches And Athletes, And Engages Fans With On-Site Activations And Special Promotions At Volunteer Village And DICK'S House Of Sport In Knoxville</p>


DICK'S Sporting Goods Extends Multi-Year Partnership With University Of Tennessee Athletics

Legal

FBLG

FibroBiologics Issued European Patent For Fibroblast Delivery Of Tumor Inhibitory Agents

An update from Northann Corp. (NCL) is now available. David M. Kratochvil has stepped down as the CFO of Northann Corp., with his resignation and s...

Northann Corp. Announces CFO Transition and New Interim Leader

<p><a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a></p>
<p><strong>Northann</strong> (NYSEMKT:<span><a href="https://investorplace.com/stock-quotes/ncl-stock-quote/"><strong>NCL</strong></a></span>) just reported results for the fourth quarter of 2023.</p><ul><li>Northann reported earnings per share of -18 cents.</li><li>The company reported revenue of $4.54 million.</li></ul><div><p>InvestorPlace Earnings is a project that leverages data from <a href="https://www.tradesmith.com">TradeSmith</a> to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at <a href="mailto:editor@investorplace.com">editor@investorplace.com</a>.</p></div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT771245">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT771236">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2021/01/one-percenter-issues-urgent-warning/?cid=MKT499868&amp;eid=MKT793997">It doesn&rsquo;t matter if you have $500 or $5 million. Do this now.</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	<p>The post <a href="https://investorplace.com/earning-results/2024/04/ncl-stock-earnings-northann-for-q4-of-2023/">NCL Stock Earnings: Northann Reported Results for Q4 2023</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.</p>

NCL Stock Earnings: Northann Reported Results for Q4 2023

Northann enters into partnership with Adornus Cabinetry

<p><a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a></p>
<p><strong>Northann</strong> (NYSEMKT:<span><a href="https://investorplace.com/stock-quotes/ncl-stock-quote/"><strong>NCL</strong></a></span>) just reported results for the first quarter of 2024.</p><ul><li>Northann reported earnings per share of 0.3 cent.</li><li>The company reported revenue of $4.60 million.</li></ul><div><p>InvestorPlace Earnings is a project that leverages data from <a href="https://www.tradesmith.com">TradeSmith</a> to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at <a href="mailto:editor@investorplace.com">editor@investorplace.com</a>.</p></div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT771245">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT771236">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2021/01/one-percenter-issues-urgent-warning/?cid=MKT499868&amp;eid=MKT793997">It doesn&rsquo;t matter if you have $500 or $5 million. Do this now.</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	<p>The post <a href="https://investorplace.com/earning-results/2024/05/ncl-stock-earnings-northann-for-q1-of-2024/">NCL Stock Earnings: Northann Reported Results for Q1 2024</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.</p>

NCL Stock Earnings: Northann Reported Results for Q1 2024

Northann reports Q1 results

Northann Corp. (NCL) has provided an update. Northann Corp. recently finalized agreements with investors Sam Yan and Hongyu Wang to settle their se...

Northann Corp. Halves Debt with Savvy Investor Settlements

<p><a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a></p>
<p>The financial media does its best to keep you informed about what&rsquo;s happening in the market. However, this has the effect of giving significant attention to a handful of leaders or laggards. That creates an opportunity for investors who have the patience to look for must-own overlooked stocks. &nbsp;</p>



<p>Overlooked stocks are not necessarily underperforming the market. In some cases, these stocks simply are slow and steady at a time when investors want to find the newest and brightest shiny object. &nbsp;</p>



<p>However, not every shiny object is <strong>Nvidia</strong> (NASDAQ:<span><a href="https://investorplace.com/stock-quotes/nvda-stock-quote/"><strong>NVDA</strong></a></span>). And the more light that starts shining on a high-profile stock, the more likely it is that the stock could move sharply lower on the slightest bit of bad news. &nbsp;</p>



<p>Another common misconception about overlooked stocks is that they come with a cheap price tag. This is also not necessarily true. In fact, sometimes a stock gets overlooked because it seems too expensive for retail investors. &nbsp;</p>



<p>In the end, must-buy overlooked stocks come down to value more than price. Because value always wins out over time. Here are seven stocks that investors are overlooking now but may shift back towards when market conditions change. &nbsp;</p>



<h2>AbbVie (ABBV)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2023/01/abbv1600-300x169.png" alt="Closeup of AbbVie (ABBV) building corporate office, an American biopharmaceutical company with its headquarters in Lake Bluff, Illinois, USA"><div>Source: Valeriya Zankovych / Shutterstock.com</div></div><p><strong>AbbVie</strong> (NYSE:<span><a href="https://investorplace.com/stock-quotes/abbv-stock-quote/"><strong>ABBV</strong></a></span>) is up 13.4% in the last 12 months but is down 11% in the last three months. The biopharmaceutical giant is being overlooked for a couple of reasons. First, with a price-to-earnings (P/E) ratio of around 40x, it&rsquo;s hardly a cheap stock. Second, investors want to see how the company&rsquo;s revenue and earnings will hold up now that its flagship Humira drug faces biosimilar competition in the U.S. and Europe.&nbsp;</p>



<p>When looking at the P/E ratio it&rsquo;s helpful to note that AbbVie has a forward P/E of around 13x earnings. That&rsquo;s much more attractive. &nbsp;</p>



<p>Then there&rsquo;s the Humira question. There&rsquo;s no doubt that the company is seeing pressure from competitors. In its April earnings report, AbbVie reported a <a href="https://investors.abbvie.com/static-files/af510304-0bc1-4781-9090-b6c4a9be5edb" target="_blank">39% decline in Humira revenue</a> in the United States. &nbsp;</p>



<p>However, AbbVie also <a href="https://investorplace.com/2024/05/7-safe-haven-stocks-to-weather-any-storm/" target="_blank">reported strong growth from two of its newer drugs</a>: Skyrizi and Rinvoq. These drugs are integral to the company&rsquo;s plans for replacing the lost Humira revenue. AbbVie also has a deep pipeline with <a href="https://www.abbvie.com/science/pipeline.html" target="_blank">50 drugs in mid- and late-stage development</a>. &nbsp;</p>



<p>Since the company&rsquo;s earnings report, analysts have assigned a <a href="https://www.tradingview.com/chart/aMepJfAr/?symbol=NYSE%3AABBV&amp;utm_source=www.marketbeat.com&amp;utm_medium=widget&amp;utm_campaign=chart-logo&amp;utm_term=NYSE%3AABBV" target="_blank">consensus price target of $182.90</a>. That&rsquo;s a 17% gain. Plus, AbbVie is a dividend king that not only has increased its dividend for 52 consecutive years, but the stock has an attractive yield of 3.98%. &nbsp;</p>



<h2>Johnson &amp; Johnson (JNJ)&nbsp;</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2019/10/jnj1600b-300x169.jpg" alt="jnj healthcare stocks"><div>Source: Raihana Asral / Shutterstock.com</div></div><p><strong>Johnson &amp; Johnson </strong>(NYSE:<span><a href="https://investorplace.com/stock-quotes/jnj-stock-quote/"><strong>JNJ</strong></a></span>) is another biopharmaceutical company on this list of must-own overlooked stocks. Unlike AbbVie, investors can&rsquo;t say that JNJ stock is expensive. It has a current P/E of 9x and a forward P/E of 13x. &nbsp;</p>



<p>Nevertheless, valuation remains an issue as investors are trying to price JNJ stock without its consumer products division that it spun off as <strong>Kenvue</strong> (NYSE:<span><a href="https://investorplace.com/stock-quotes/kvue-stock-quote/"><strong>KVUE</strong></a></span>) in 2023. The company is also working to resolve its long-running lawsuits stemming from its talc powder. In January, AbbVie announced it was moving forward on a <a href="https://www.cnn.com/2024/05/01/business/j-and-j-talc-cancer-lawsuits-settlement/index.html" target="_blank">$6.475 billion proposed settlement</a> of tens of thousands of lawsuits. However, there <a href="https://www.foxbusiness.com/markets/johnson-johnson-sued-cancer-victims-fraudulent-bankruptcies" target="_blank">may still be some work to do</a>. &nbsp;</p>



<p>The past shouldn&rsquo;t be overlooked. But the bullish case for JNJ stock is about the future. And its acquisition of<strong> Shockwave Medical</strong> (NASDAQ:<span><a href="https://investorplace.com/stock-quotes/swav-stock-quote/"><strong>SWAV</strong></a></span>) is a key part of that. The <a href="https://investorplace.com/2024/04/wall-street-favorites-3-dividend-stocks-with-strong-buy-ratings-for-april-2024/" target="_blank">$13.1 billion acquisition</a> will bring Shockwave&rsquo;s first-to-market intravascular lithotripsy technology (ILT) under Johnson &amp; Johnson&rsquo;s MedTech division. &nbsp;</p>



<p>Once this acquisition becomes accretive to JNJ&rsquo;s top and bottom lines, JNJ stock will look extremely attractive for more than just its dividend which has a 3.48% yield. And with 62 years of consecutive dividend increases, Johnson &amp; Johnson is another dividend king on this list. &nbsp;</p>



<h2>PepsiCo (PEP)&nbsp;</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2022/02/pep-pepsico-1600-300x169.png" alt="Pepsi (PEP) Factory in Samara, Russia. Pepsi logo on a blue warehouse."><div>Source: FotograFFF / Shutterstock</div></div><p><strong>PepsiCo</strong> (NASDAQ:<span><a href="https://investorplace.com/stock-quotes/pep-stock-quote/"><strong>PEP</strong></a></span>) is the third and final dividend king on this list of must-own overlooked stocks. The consumer staples giant has been largely able to <a href="https://investorplace.com/2024/05/7-reliable-blue-chip-stocks-that-cannot-miss/" target="_blank">pass along some of its higher producer costs</a>. But growth is slowing, and there is concern that consumer spending is slowing as well. Just as Pepsi benefits from both beverage and snack food sales when consumers trade up, it can suffer when consumers trade down. &nbsp;</p>



<p>This pessimism is reflected in PEP stock, which is essentially flat in 2024 and down about 5% in the last 12 months. That&rsquo;s not a massive dip to buy, but the stock is trading at around $170 which has served as a level of support and resistance in the last two years. &nbsp;</p>



<p>History shows that buying dips, no matter how small, in PEP stock is a solid strategy. One reason has to do with the company&rsquo;s previously mentioned dividend which yields 2.96% as of this writing and has been growing for 53 consecutive years. &nbsp;</p>



<h2>Sofi Technologies (SOFI)&nbsp;</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2023/10/sofi1600-1-300x169.png" alt="SoFi Technologies, Inc logo with stock market chart background. is an American online personal finance company and online bank."><div>Source: Poetra.RH / Shutterstock.com</div></div><p><strong>Sofi Technologies</strong> (NASDAQ:<span><a href="https://investorplace.com/stock-quotes/sofi-stock-quote/"><strong>SOFI</strong></a></span>) falls under the category of &ldquo;yeah, but&rdquo; stocks. Okay, I invented the category, but the premise is this. Sofi has largely delivered what it has said it would do. It was an online lender primarily known for providing student loans. Yeah, but it wasn&rsquo;t a real bank. Then it got its&nbsp;bank charter. Yeah, but it wasn&rsquo;t profitable. Now it&rsquo;s delivered two straight quarters of positive adjusted EPS. &nbsp;</p>



<p>Still the stock can&rsquo;t seem to get out of the snares of short sellers. A considerable 18% of the SOFI stock float is being shorted. And with only 38% of the shares owned by institutions, it&rsquo;s been a tough hold. &nbsp;</p>



<p>SOFI stock is bouncing around $6.80. The good news is this has been a solid level of support. The bad news is that the company continues to revisit this level. The key will come from future growth, and in that regard being an internet-only bank <a href="https://investorplace.com/2024/05/secret-stocks-with-sizzle-3-low-profile-picks-packing-high-profit-potential/" target="_blank">lowers the company&rsquo;s customer acquisition costs</a>. &nbsp;</p>



<h2>Pfizer (PFE)&nbsp;</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2019/08/pfe-stock-2-300x169.jpg" alt="blue Pfizer logo on the windows of a corporate building PFR stock"><div>Source: photobyphm / Shutterstock.com</div></div><p><strong>Pfizer</strong> (NYSE:<span><a href="https://investorplace.com/stock-quotes/pfe-stock-quote/"><strong>PFE</strong></a></span>) is down 24% in the last 12 months and nearly 50% since its peak of near $60 in November 2021. The rise and fall of PFE stock was entirely predictable. The company was first-to-market with a vaccine for Covid-19. And it enjoyed the benefits of that position in its revenue and earnings. &nbsp;</p>



<p>However, as demand for the company&rsquo;s Covid-19 products wanes, so does the stock which is facing difficult comparisons. That said, Pfizer is being overlooked for many reasons, some of which have nothing to do with the intrinsic value of the stock. &nbsp;</p>



<p>That&rsquo;s part of the buying thesis. The mRNA technology that was used in the Covid-19 vaccine is already being used to develop other vaccines. The company is also making strides in oncology as well as areas such as <a href="https://www.pfizer.com/science" target="_blank">gene therapy and precision medicine</a>. And Pfizer has the balance sheet to get these products to the finish line whether it goes alone or through acquisition. &nbsp;</p>



<p>Analysts have a consensus Hold rating on PFE stock, but the price target is 37% higher. That&rsquo;s a discrepancy that makes it tempting to start a position. That&rsquo;s particularly true because, while you wait, you&rsquo;re getting a dividend with a 5.97% yield. &nbsp;</p>



<h2>Enphase Energy (ENPH)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2023/07/enph1600-300x169.png" alt="Smartphone with logo of American company company Enphase Energy Inc. (ENPH) on screen in front of business website. Focus on left of phone display. Unmodified photo."><div>Source: T. Schneider / Shutterstock.com</div></div><p><a href="https://investorplace.com/industries/energy/renewable-energy/solar/">Solar stocks</a> have been hit and miss for investors. There are stocks like <strong>First Solar</strong> (NASDAQ:<span><a href="https://investorplace.com/stock-quotes/fslr-stock-quote/"><strong>FSLR</strong></a></span>) that are ripping higher. But a company like <strong>Enphase Energy </strong>(NYSE:<span><a href="https://investorplace.com/stock-quotes/enph-stock-quote/"><strong>ENPH</strong></a></span>), which was a darling of the solar sector in 2021 and 2022 has been having a rough time. &nbsp;</p>



<p>The company serves a largely residential audience and has been faced with declining revenue which has caused earnings to turn negative. Simply put, Enphase desperately needs a rate cut that will stimulate home buying and consumer investment in solar technology. &nbsp;</p>



<p>That may have to wait until 2025, but here&rsquo;s why you may want to put Enphase on a list of must-own overlooked stocks. Analysts have a consensus price target of $127.12. That&rsquo;s 2% lower than the price as of this writing. But <a href="https://www.tradingview.com/chart/aMepJfAr/?symbol=NASDAQ%3AENPH&amp;utm_source=www.marketbeat.com&amp;utm_medium=widget&amp;utm_campaign=chart-logo&amp;utm_term=NASDAQ%3AENPH" target="_blank">22 out of 42 analysts give ENPH stock a Strong Buy or Buy rating</a>. That suggests there may be a bigger dip coming for ENPH stock, but that would be a good time to take a position. &nbsp;</p>



<h2>Norwegian Cruise Line (NCLH)&nbsp;</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2022/06/nclh-1600-1-300x169.jpg" alt="Norwegian Cruise Line ship arriving at a port. NCLH stock."><div>Source: Ian_Stewart / Shutterstock</div></div><p>Cruise line stocks were a no-brainer long-term buy in 2020 and 2021. The industry was decimated by the global pandemic. But the smart money knew the industry would come back as it has. However, <strong>Norwegian Cruise Line</strong> (NYSE:<span><a href="https://investorplace.com/stock-quotes/nclh-stock-quote/"><strong>NCLH</strong></a></span>) has been largely ignored. Investors have a high bar and little patience. All it took was a slight miss on the top line to spook investors and turn NCLH stock negative for the year.&nbsp;</p>



<p>But this could be the stock&rsquo;s time to shine. Analysts are lining up behind Norwegian on expectations of earnings growth that could reach 30%, not just this year but for each of the next three years. That would help the cruise line retire a significant chunk of the $14 billion net debt load it&rsquo;s still carrying. &nbsp;</p>



<p>To deliver on those projections, it seems like the company is counting on younger travelers. The company recently cited millennial and Gen-Z passengers as being its <a href="https://www.nbclosangeles.com/news/business/money-report/norwegian-cruise-line-ceo-says-millennials-and-gen-z-are-the-fastest-growing-segment/3416765/" target="_blank">fastest growing demographic</a>. That could be a double-edged sword if the economy worsens. However, over time these are the passengers that will have growing income to spend on experiences. &nbsp;</p>



<p><em>On the date of publication, Chris Markoch did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the </em>InvestorPlace.com<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank"><em> </em>Publishing Guidelines.</a>&nbsp;</p>
<div><p>Chris Markoch is a freelance financial copywriter who has been covering the market for over five years. He has been writing for InvestorPlace since 2019.</p></div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT802110">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT766411">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget A.I. THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	
<p>The post <a href="https://investorplace.com/2024/06/7-must-own-overlooked-stocks-that-can-work-in-any-portfolio/">7 Overlooked Stocks That Belong in Every Portfolio </a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.</p>

7 Overlooked Stocks That Belong in Every Portfolio

<p><a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a></p>
<p>We have all of the biggest pre-market stock movers that traders will want to read about on Monday morning!</p>



<p>Moving stocks this morning an investor update, clinical trial news, a private offering and more.</p>



<p>Let&rsquo;s get into that news below!</p>



<h2>Biggest Pre-Market Stock Movers: 10 Top Gainers</h2>



<ol><li><strong>Scinai Immunotherapeutics</strong> (NASDAQ:<a href="https://investorplace.com/stock-quotes/scni-stock-quote/"><strong>SCNI</strong></a>) stock is rocketing more than 69% alongside heavy pre-market trading.</li>



<li><strong>Schmid Group</strong> (NASDAQ:<span><a href="https://investorplace.com/stock-quotes/shmd-stock-quote/"><strong>SHMD</strong></a></span>) shares are soaring 40% without any clear news this morning.</li>



<li><strong>ENDRA Life Sciences</strong> (NASDAQ:<a href="https://investorplace.com/stock-quotes/ndra-stock-quote/"><strong>NDRA</strong></a>) stock is surging over 36% alongside an <a href="https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&amp;ref=318395592&amp;type=PDF&amp;symbol=NDRA&amp;cdn=4506ae3b1a739822361489bedc53ef84&amp;companyName=ENDRA+Life+Sciences+Inc.&amp;formType=SC+13G&amp;formDescription=Statement+of+acquisition+of+beneficial+ownership+by+individuals&amp;dateFiled=2024-06-14">investor stake update</a>.</li>



<li><strong>Maxeon Solar Technologies</strong> (NASDAQ:<a href="https://investorplace.com/stock-quotes/maxn-stock-quote/"><strong>MAXN</strong></a>) shares are rising more than 21% with strong early morning trading.</li>



<li><strong>Srivaru </strong>(NASDAQ:<a href="https://investorplace.com/stock-quotes/svmh-stock-quote/"><strong>SVMH</strong></a>) stock is increasing over 18% as it continues to <a href="https://investorplace.com/2024/06/why-is-srivaru-svmh-stock-up-122-today/">rally on e-bike news</a>.</li>



<li><strong>Nurix Therapeutics</strong> (NASDAQ:<a href="https://investorplace.com/stock-quotes/nrix-stock-quote/"><strong>NRIX</strong></a>) shares are gaining 17% on <a href="https://www.marketwatch.com/story/nurix-therapeutics-shares-rise-on-positive-leukemia-drug-results-66b9d524?mod=investing">positive drug results</a>.</li>



<li><strong>Icecure Medical</strong> (NASDAQ:<a href="https://investorplace.com/stock-quotes/iccm-stock-quote/"><strong>ICCM</strong></a>) stock is getting a 14% boost with it still rallying on <a href="https://www.nasdaq.com/press-release/positive-data-icecures-kidney-cancer-clinical-study-presented-interventional">kidney cancer study data</a>.</li>



<li><strong>Kineta </strong>(NASDAQ:<a href="https://investorplace.com/stock-quotes/ka-stock-quote/"><strong>KA</strong></a>) shares are heading more than 13% higher with heavy trading today.</li>



<li><strong>XTL Biopharmaceuticals</strong> (NASDAQ:<a href="https://investorplace.com/stock-quotes/xtlb-stock-quote/"><strong>XTLB</strong></a>) stock is jumping over 12% this morning.</li>



<li><strong>Conn&rsquo;s </strong>(NASDAQ:<a href="https://investorplace.com/stock-quotes/conn-stock-quote/"><strong>CONN</strong></a>) shares are up more than 11% today.</li>
</ol><h2>10 Top Losers</h2>



<ol><li><strong>Kaival Brands Innovations</strong> (NASDAQ:<a href="https://investorplace.com/stock-quotes/kavl-stock-quote/"><strong>KAVL</strong></a>) stock is plummeting more than 35% after a massive rally on Friday.</li>



<li><strong>Sonim Technologies</strong> (NASDAQ:<a href="https://investorplace.com/stock-quotes/sonm-stock-quote/"><strong>SONM</strong></a>) shares are diving over 25% this morning.</li>



<li><strong>AMC Networks</strong> (NASDAQ:<a href="https://investorplace.com/stock-quotes/amcx-stock-quote/"><strong>AMCX</strong></a>) stock is tumbling more than 23% after <a href="https://www.nasdaq.com/press-release/amc-networks-inc-announces-private-offering-125-million-convertible-senior-notes-2024">announcing a private offering</a>.</li>



<li><strong>Bluejay Diagnostics</strong> (NASDAQ:<a href="https://investorplace.com/stock-quotes/bjdx-stock-quote/"><strong>BJDX</strong></a>) shares are taking an over 17% beating despite a lack of news.</li>



<li><strong>Northann </strong>(NYSEMKT:<a href="https://investorplace.com/stock-quotes/ncl-stock-quote/"><strong>NCL</strong></a>) stock is falling close to 14% without any news to report.</li>



<li><strong>Zapp Electric Vehicles</strong> (NASDAQ:<a href="https://investorplace.com/stock-quotes/zapp-stock-quote/"><strong>ZAPP</strong></a>) shares are dropping more than 13% as it <a href="https://investorplace.com/2024/06/why-is-zapp-electric-vehicles-zapp-stock-up-173-today/">comes off a rally last week</a>.</li>



<li><strong>Aptevo Therapeutics</strong> (NASDAQ:<a href="https://investorplace.com/stock-quotes/apvo-stock-quote/"><strong>APVO</strong></a>) stock is decreasing over 13% on a <a href="https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&amp;ref=318396271&amp;type=PDF&amp;symbol=APVO&amp;cdn=21e6c068c48621c307f0f74bc8553007&amp;companyName=Aptevo+Therapeutics+Inc.&amp;formType=S-1&amp;formDescription=Registration+statement+under+Securities+Act+of+1933&amp;dateFiled=2024-06-14">proposed public offering</a>.</li>



<li><strong>Feutune Light Acquisition</strong> (NASDAQ:<a href="https://investorplace.com/stock-quotes/flfv-stock-quote/"><strong>FLFV</strong></a>) shares are slipping almost 12% on Monday.</li>



<li><strong>Volcon </strong>(NASDAQ:<a href="https://investorplace.com/stock-quotes/vlcn-stock-quote/"><strong>VLCN</strong></a>) stock is dipping more than 11% on <a href="https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&amp;ref=318396398&amp;type=PDF&amp;symbol=VLCN&amp;cdn=980b1d9c3f018f25ac11de4d0e102b66&amp;companyName=Volcon+Inc.&amp;formType=8-K&amp;formDescription=Current+report+pursuant+to+Section+13+or+15%28d%29&amp;dateFiled=2024-06-14">a delisting notice</a>.</li>



<li><strong>Holdco Nuvo</strong> (NASDAQ:<a href="https://investorplace.com/stock-quotes/nuvo-stock-quote/"><strong>NUVO</strong></a>) shares close out our pre-market stock movers down over 11% today.</li>
</ol><p><em>On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the&nbsp;InvestorPlace.com&nbsp;</em><a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank"><em>Publishing Guidelines</em></a><em>.</em></p>
<h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT802110">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT766411">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget A.I. THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	<p>The post <a href="https://investorplace.com/2024/06/todays-biggest-pre-market-stock-movers-10-top-gainers-and-losers-on-monday-june-17th/">Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.</p>

Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday

Northann Corp. (NCL) has shared an update. Northann Corp. has announced its relocation to a new headquarters in South Carolina, having entered into...

Northann Corp.: Strategic Headquarters Relocation and Lease Deal

<p><a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a></p>
<p><strong>Northann</strong> (NYSEMKT:<span><a href="https://investorplace.com/stock-quotes/ncl-stock-quote/"><strong>NCL</strong></a></span>) just reported results for the second quarter of 2024.</p><ul><li>Northann reported earnings per share of -4 cents.</li><li>The company reported revenue of $3.89 million.</li></ul><div><p>InvestorPlace Earnings is a project that leverages data from <a href="https://www.tradesmith.com">TradeSmith</a> to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at <a href="mailto:editor@investorplace.com">editor@investorplace.com</a>.</p></div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget AI... THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul><p>The post <a href="https://investorplace.com/earning-results/2024/08/ncl-stock-earnings-northann-for-q2-of-2024/">NCL Stock Earnings: Northann Reported Results for Q2 2024</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.</p>

NCL Stock Earnings: Northann Reported Results for Q2 2024

ABBV

AMCX

APVO

BJDX

CONN

ENPH

FLFV

FSLR

ICCM

KAVL

KVUE

MAXN

NDRA

NRIX

NUVO

SCNI

SHMD

SOFI

SONM

SVMH

SWAV

VLCN

XTLB

ZAPP

Press Releases

Northann Corp.'s Benchwick Brand to Showcase SuperOak Hybrid Wood Planks Alongside Blue11 Collection at NWFA in New Orleans, April 16-18, 2024

Expo Presentations and Cross-Licensing with I4F to Expand Business for 3D-Printed Ecosystem Flooring and Wall Panel Products Made with Recycled Ocean Plastics: Northann Corp (NYSE: NCL)

Northann Corp Enters Strategic Relationship with Rexil Group of Companies Netherlands to Promote Sustainable Technology and Products

Strategic Relationships Cross-Licensing and Sourcing are Globally Expanding 3D-Printed Ecosystem Flooring and Wall Panel Products Made with Recycled Ocean Plastics: Northann Corp. (NYSE: NCL)

Northann Corp.'s Blue11-Ocean Plastic Flooring and Wall Panels Product Wins Multiple Prestigious Awards in 2024

6 Prestigious Awards and Expanding Global Marketing and Licensing for Eco-Friendly 3D-Printed Flooring & Wall Panel Products Made Using Recycled Ocean Plastics: Northann Corp. (NYSE: NCL)

Northann Corp. Announces Strategic Partnership with Adornus Cabinetry

Relationships with Adornus Cabinetry, Rexil Group and I4F; Multiple Awards for 3D-Printed Flooring & Wall Panel Products Made Using Recycled Ocean Plastics: Northann Corp. (NYSE: NCL)

Comments

Northann

Noticias

Últimas noticias sobre Northann (AMEX:NCL) Bolsa

La gente también mira

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL